A. Vincent et al., ANTIBODIES TO I-125 GLUTAMIC-ACID DECARBOXYLASE IN PATIENTS WITH STIFF MAN SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 62(4), 1997, pp. 395-397
Antibodies to glutamic acid decarboxylase (GAD) are found in about 40%
of patients with stiff man syndrome. A new assay involving immunoprec
ipitation of I-125-glutamic acid decarboxylase was used to measure ant
i-GAD antibodies in 18 patients with stiff man syndrome. Of the eight
serum samples from patients with stiff man syndrome, that had previous
ly been found positive by immunoprecipitation of S-35-GAD, seven were
strongly positive with I-125-GAD and one gave an equivocal result. Oth
er serum samples from patients with stiff man syndrome and from contro
ls were negative except one from a patient who had a thymoma, acquired
neuromyotonia, and myasthenia gravis. Nine of 35 serum samples referr
ed for testing were positive; in two of these the serum titre was 20-5
0 times higher than that in the CSF. This assay should prove useful in
the diagnosis, management, and investigation of stiff man syndrome.